Pfizer to internally split generic, branded drugs operations

(Reuters) – Pfizer Inc on Monday said it plans to internally separate its commercial operations into three business segments, including two units that sell patent-protected branded drugs and one that sells generic medicines.

Powered by WPeMatico

This entry was posted in World News. Bookmark the permalink.

Comments are closed.